Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
about
Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice.Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.
P2860
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
@ast
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
@en
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
@nl
type
label
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
@ast
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
@en
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
@nl
prefLabel
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
@ast
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
@en
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
@nl
P2093
P2860
P356
P1476
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
@en
P2093
Altomonte L
Di Cesare L
Ricerca BM
P2860
P304
P356
10.1136/ARD.49.4.268-B
P407
P577
1990-04-01T00:00:00Z